Synopsis
0
JDMF
0
EU WC
0
KDMF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Direct Compression
Chewable & Orodispersible Aids
Taste Masking
Parenteral
Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
86
PharmaCompass offers a list of Diclazuril API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diclazuril manufacturer or Diclazuril supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diclazuril manufacturer or Diclazuril supplier.
PharmaCompass also assists you with knowing the Diclazuril API Price utilized in the formulation of products. Diclazuril API Price is not always fixed or binding as the Diclazuril Price is obtained through a variety of data sources. The Diclazuril Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vecoxan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vecoxan, including repackagers and relabelers. The FDA regulates Vecoxan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vecoxan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Vecoxan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Vecoxan supplier is an individual or a company that provides Vecoxan active pharmaceutical ingredient (API) or Vecoxan finished formulations upon request. The Vecoxan suppliers may include Vecoxan API manufacturers, exporters, distributors and traders.
click here to find a list of Vecoxan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Vecoxan DMF (Drug Master File) is a document detailing the whole manufacturing process of Vecoxan active pharmaceutical ingredient (API) in detail. Different forms of Vecoxan DMFs exist exist since differing nations have different regulations, such as Vecoxan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Vecoxan DMF submitted to regulatory agencies in the US is known as a USDMF. Vecoxan USDMF includes data on Vecoxan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Vecoxan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Vecoxan suppliers with USDMF on PharmaCompass.
A Vecoxan CEP of the European Pharmacopoeia monograph is often referred to as a Vecoxan Certificate of Suitability (COS). The purpose of a Vecoxan CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Vecoxan EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Vecoxan to their clients by showing that a Vecoxan CEP has been issued for it. The manufacturer submits a Vecoxan CEP (COS) as part of the market authorization procedure, and it takes on the role of a Vecoxan CEP holder for the record. Additionally, the data presented in the Vecoxan CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Vecoxan DMF.
A Vecoxan CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Vecoxan CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Vecoxan suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Vecoxan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Vecoxan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Vecoxan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Vecoxan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Vecoxan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Vecoxan suppliers with NDC on PharmaCompass.
Vecoxan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vecoxan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vecoxan GMP manufacturer or Vecoxan GMP API supplier for your needs.
A Vecoxan CoA (Certificate of Analysis) is a formal document that attests to Vecoxan's compliance with Vecoxan specifications and serves as a tool for batch-level quality control.
Vecoxan CoA mostly includes findings from lab analyses of a specific batch. For each Vecoxan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vecoxan may be tested according to a variety of international standards, such as European Pharmacopoeia (Vecoxan EP), Vecoxan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vecoxan USP).
